##chargement des packages----
library(questionr)
library(tidyverse)
## ── Attaching core tidyverse packages ──────────────────────── tidyverse 2.0.0 ──
## ✔ dplyr 1.1.1 ✔ readr 2.1.4
## ✔ forcats 1.0.0 ✔ stringr 1.5.0
## ✔ ggplot2 3.4.2 ✔ tibble 3.2.1
## ✔ lubridate 1.9.2 ✔ tidyr 1.3.0
## ✔ purrr 1.0.1
## ── Conflicts ────────────────────────────────────────── tidyverse_conflicts() ──
## ✖ dplyr::filter() masks stats::filter()
## ✖ dplyr::lag() masks stats::lag()
## ℹ Use the conflicted package (<http://conflicted.r-lib.org/>) to force all conflicts to become errors
library(tableone)
library(labelled)
library(gtsummary)
library(GGally)
## Registered S3 method overwritten by 'GGally':
## method from
## +.gg ggplot2
library(readxl)
library(effects)
## Le chargement a nécessité le package : carData
## lattice theme set by effectsTheme()
## See ?effectsTheme for details.
library(survival)
library(survminer)
## Le chargement a nécessité le package : ggpubr
##
## Attachement du package : 'survminer'
##
## L'objet suivant est masqué depuis 'package:survival':
##
## myeloma
library(ggplot2)
library(dplyr)
library(knitr)
library(cowplot)
##
## Attachement du package : 'cowplot'
##
## L'objet suivant est masqué depuis 'package:ggpubr':
##
## get_legend
##
## L'objet suivant est masqué depuis 'package:lubridate':
##
## stamp
library(readxl)
ct_classe <- read_excel("C:/datar/ct_classe.xlsx")
##recodage des variables et bases de données le cas échéant----
var_label(ct_classe$tox_dig) <- "Toxicité digestive"
var_label(ct_classe$tox_muq) <- "Toxicité muqueuse"
var_label(ct_classe$tox_cut) <- "Toxicité cutanée"
var_label(ct_classe$tox_cardio) <- "Toxicité cardiovasculaire"
var_label(ct_classe$tox_oph) <- "Toxicité ophtalmique"
var_label(ct_classe$tox_plum) <- "Toxicité pulmonaire"
var_label(ct_classe$tox_gale) <- "Toxicité générale"
var_label(ct_classe$tox_hemato) <- "Toxicité hématologique"
var_label(ct_classe$tox_musq_os) <- "Toxicité musqulosqueletique"
var_label(ct_classe$tox_rein) <- "Toxicité rénale"
var_label(ct_classe$tox_foie) <- "Toxicité hépatique"
var_label(ct_classe$tox_neuro) <- "Toxicité neuroologique"
var_label(ct_classe$tox_psy) <- "Toxicité psychiatrique"
var_label(ct_classe$tox_bio) <- "Toxicité biologique"
##renommer des variables pour présentation dans les tableaux de résultat
tbl_summary(
ct_classe, include = c("tox_dig", "tox_muq", "tox_cut",
"tox_cardio", "tox_oph", "tox_plum",
"tox_gale","tox_hemato" ,"tox_musq_os", "tox_rein",
"tox_foie", "tox_neuro", "tox_psy", "tox_bio"),
statistic = all_continuous() ~ "{median} [{min} - {max}]",
digits=all_categorical()~ c(0,1)
)
Characteristic |
N = 65 |
Toxicité digestive |
|
acidité gastrique |
1 (2.4%) |
constipation |
10 (23.8%) |
diarrhée |
12 (28.6%) |
diarrhée brûlure anus nausée |
1 (2.4%) |
diarrhée douleur gorge |
1 (2.4%) |
diarrhée gaz |
1 (2.4%) |
diarrhée nausée |
1 (2.4%) |
douleur au ventre |
2 (4.8%) |
douleur gastrique |
2 (4.8%) |
douleurs gastriques |
1 (2.4%) |
gastrite diarrhée constipation nausée |
1 (2.4%) |
nausée |
2 (4.8%) |
nausée constipation |
1 (2.4%) |
nausée vomissement |
1 (2.4%) |
nausée vomissement diarrhée |
1 (2.4%) |
pesanteur gastrique |
1 (2.4%) |
pyrosis |
1 (2.4%) |
selles impérieuses |
1 (2.4%) |
vomissement |
1 (2.4%) |
Unknown |
23 |
Toxicité muqueuse |
|
Aphtes |
3 (17.6%) |
Gencives fragilisée |
1 (5.9%) |
Gingivite |
1 (5.9%) |
Hyposialies nocturnes |
1 (5.9%) |
Langue rouge |
1 (5.9%) |
Mucite |
2 (11.8%) |
Mucites, sécheresse |
1 (5.9%) |
Sécheresse |
1 (5.9%) |
Sècheresse |
1 (5.9%) |
Sécheresse buccale |
2 (11.8%) |
Sècheresse buccale |
1 (5.9%) |
Sécheresse vaginale |
1 (5.9%) |
Stomatite |
1 (5.9%) |
Unknown |
48 |
Toxicité cutanée |
|
Abcès frottement culotte |
1 (3.3%) |
Acné juvénile |
1 (3.3%) |
Boutons |
1 (3.3%) |
Boutons, crevasse |
1 (3.3%) |
Boutons, prurit |
1 (3.3%) |
Boutons, rash, sécheresse |
1 (3.3%) |
Boutons, sécheresse |
1 (3.3%) |
Cheveux cassants |
1 (3.3%) |
Croûtes cuir chevelu |
1 (3.3%) |
Eruption cutanée granuleuse, crevasses |
1 (3.3%) |
Eruptions acnéiformes |
1 (3.3%) |
Escarre |
1 (3.3%) |
Ongles fragiles |
1 (3.3%) |
Prurit et couperoses |
1 (3.3%) |
Prurit, pellicules |
1 (3.3%) |
Prurit, rougeurs |
1 (3.3%) |
Rash |
3 (10.0%) |
Rash, sécheresse |
1 (3.3%) |
Rash, sécheresse, ongle incarné |
1 (3.3%) |
Sécheresse |
5 (16.7%) |
Sécheresse buccale, nez bouché |
1 (3.3%) |
Sécheresse, éruption |
1 (3.3%) |
Sécheresse, fissure, brûlure |
1 (3.3%) |
Sécheresse, rash |
1 (3.3%) |
Unknown |
35 |
Toxicité cardiovasculaire |
|
Augmentation volume jambes et cuisses |
1 (6.7%) |
Hypertension |
3 (20.0%) |
Jambes lourdes |
2 (13.3%) |
Oedème |
1 (6.7%) |
Œdème |
4 (26.7%) |
Oedèmes MI et visage, tachycardie |
1 (6.7%) |
Palpitations |
1 (6.7%) |
Thrombose |
1 (6.7%) |
Thrombose veineuse |
1 (6.7%) |
Unknown |
50 |
Toxicité ophtalmique |
|
Carré noir champ de vision |
1 (16.7%) |
Difficulté à l'accomodation |
1 (16.7%) |
Diploplie, vision floue, perte des couleurs |
1 (16.7%) |
Halo oculaire |
1 (16.7%) |
Sécheresse oculaire |
2 (33.3%) |
Unknown |
59 |
Toxicité pulmonaire |
|
Dyspnée |
3 (20.0%) |
Laryngite |
1 (6.7%) |
Mucus |
1 (6.7%) |
Mucus jaunes |
1 (6.7%) |
Oppression thoracique |
1 (6.7%) |
Toux |
5 (33.3%) |
Toux, dyspnée |
1 (6.7%) |
Toux, mucus épais |
1 (6.7%) |
Toux, oppression thoracique |
1 (6.7%) |
Unknown |
50 |
Toxicité générale |
|
Asthénie |
5 (20.0%) |
Asthénie, perte d'appétit |
4 (16.0%) |
Asthénie, perte de poids, agueusie |
1 (4.0%) |
Asthénie, perte de poids, dysgueusie |
1 (4.0%) |
Dysgueusie |
1 (4.0%) |
Fatigue, perte d'appétit |
1 (4.0%) |
Kyste sébacé dorsal, maux de gorge |
1 (4.0%) |
Perte d'appétit |
5 (20.0%) |
Perte de poids |
5 (20.0%) |
Perte de poids, anosmie, dysgueusie |
1 (4.0%) |
Unknown |
40 |
Toxicité hématologique |
|
Anémie |
1 (16.7%) |
Epistaxis |
3 (50.0%) |
Hématome |
1 (16.7%) |
Thrombopénie |
1 (16.7%) |
Unknown |
59 |
Toxicité musqulosqueletique |
|
Crampes |
2 (9.1%) |
Cruralgie, épanchement de la cheville |
1 (4.5%) |
Douleur |
1 (4.5%) |
Douleur au genou |
1 (4.5%) |
Douleur aux mollets |
1 (4.5%) |
Douleur dorsale |
1 (4.5%) |
Douleur dos, cervicales |
1 (4.5%) |
Douleurs |
5 (22.7%) |
Douleurs articulaires |
1 (4.5%) |
Faiblesse à la jambe |
1 (4.5%) |
Faiblesse musculaire |
1 (4.5%) |
Fatigue musculaire, douleur au pied |
1 (4.5%) |
Fracture du fémur |
1 (4.5%) |
Fracture du poignet |
1 (4.5%) |
Fracture, douleur |
1 (4.5%) |
Mysthénie |
1 (4.5%) |
tendinite |
1 (4.5%) |
Unknown |
43 |
Toxicité rénale |
|
Infections urinaires |
1 (25.0%) |
insuffisance renale aigue fonctionnelle |
1 (25.0%) |
Suspiscion d'infection urinaire |
1 (25.0%) |
Urines foncées |
1 (25.0%) |
Unknown |
61 |
Toxicité hépatique |
|
Ascite |
1 (33.3%) |
Douleur au foie |
2 (66.7%) |
Unknown |
62 |
Toxicité neuroologique |
|
Céphalée, vertige |
1 (9.1%) |
céphalées |
1 (9.1%) |
Confusion |
1 (9.1%) |
Paresthésie |
2 (18.2%) |
Syndrome de la queue de cheval, tremblements |
1 (9.1%) |
Tremblement, paresthésie |
1 (9.1%) |
Trouble du sommeil |
2 (18.2%) |
Vertige |
1 (9.1%) |
Vertige, céphalée |
1 (9.1%) |
Unknown |
54 |
Toxicité psychiatrique |
|
Anxiété |
2 (33.3%) |
Dépression |
1 (16.7%) |
Trouble de l'humeur |
2 (33.3%) |
Trouble du sommeil |
1 (16.7%) |
Unknown |
59 |
Toxicité biologique |
|
Augmentation cholestérol, glycémie 0,6 |
1 (12.5%) |
Augmentation CPK |
2 (25.0%) |
Augmentation des CPK |
2 (25.0%) |
Augmentation PAL et CPK |
1 (12.5%) |
hypokaliémie |
1 (12.5%) |
Hypokaliémie |
1 (12.5%) |
Unknown |
57 |
##
tbl_summary(
ct_classe, include = c("tox_dig", "tox_cut", "tox_muq",
"tox_cardio", "tox_oph", "tox_plum",
"tox_gale","tox_hemato" ,"tox_musq_os", "tox_rein",
"tox_foie", "tox_neuro", "tox_psy", "tox_bio"),
statistic = all_continuous() ~ "{median} [{min} - {max}]",
by="medt",
digits=all_categorical()~ c(0,1)
)
Characteristic |
Afatinib, N = 5 |
Alectinib, N = 5 |
Brigatinib, N = 6 |
Cabozantinib, N = 2 |
Crizotinib, N = 2 |
Dabrafénib/Trametinib, N = 1 |
Evérolimus, N = 4 |
Lenvatinib, N = 1 |
Lorlatinib, N = 5 |
Mobocertinib, N = 2 |
Osimertinib, N = 26 |
Osimertinib/Crizotinib, N = 1 |
Sotorasib, N = 5 |
Toxicité digestive |
|
|
|
|
|
|
|
|
|
|
|
|
|
acidité gastrique |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (25.0%) |
constipation |
0 (0.0%) |
3 (100.0%) |
0 (NA%) |
1 (100.0%) |
2 (100.0%) |
1 (100.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (0.0%) |
2 (11.1%) |
0 (0.0%) |
0 (0.0%) |
diarrhée |
3 (60.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (0.0%) |
7 (38.9%) |
0 (0.0%) |
1 (25.0%) |
diarrhée brûlure anus nausée |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
diarrhée douleur gorge |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (5.6%) |
0 (0.0%) |
0 (0.0%) |
diarrhée gaz |
1 (20.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
diarrhée nausée |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
douleur au ventre |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
2 (11.1%) |
0 (0.0%) |
0 (0.0%) |
douleur gastrique |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
2 (100.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
douleurs gastriques |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (5.6%) |
0 (0.0%) |
0 (0.0%) |
gastrite diarrhée constipation nausée |
1 (20.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
nausée |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (5.6%) |
0 (0.0%) |
1 (25.0%) |
nausée constipation |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (25.0%) |
nausée vomissement |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (5.6%) |
0 (0.0%) |
0 (0.0%) |
nausée vomissement diarrhée |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (5.6%) |
0 (0.0%) |
0 (0.0%) |
pesanteur gastrique |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (5.6%) |
0 (0.0%) |
0 (0.0%) |
pyrosis |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (5.6%) |
0 (0.0%) |
0 (0.0%) |
selles impérieuses |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (100.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
vomissement |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (100.0%) |
0 (0.0%) |
Unknown |
0 |
2 |
6 |
1 |
0 |
0 |
2 |
0 |
3 |
0 |
8 |
0 |
1 |
Toxicité cutanée |
|
|
|
|
|
|
|
|
|
|
|
|
|
Abcès frottement culotte |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
Acné juvénile |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
Boutons |
0 (0.0%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Boutons, crevasse |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
Boutons, prurit |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
Boutons, rash, sécheresse |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
Boutons, sécheresse |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Cheveux cassants |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Croûtes cuir chevelu |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Eruption cutanée granuleuse, crevasses |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
Eruptions acnéiformes |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
Escarre |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
Ongles fragiles |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
Prurit et couperoses |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
Prurit, pellicules |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
Prurit, rougeurs |
0 (0.0%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Rash |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
1 (50.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
Rash, sécheresse |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
Rash, sécheresse, ongle incarné |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
Sécheresse |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
3 (18.8%) |
0 (NA%) |
0 (0.0%) |
Sécheresse buccale, nez bouché |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
Sécheresse, éruption |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
1 (50.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Sécheresse, fissure, brûlure |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
Sécheresse, rash |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Unknown |
1 |
3 |
6 |
2 |
2 |
0 |
3 |
1 |
4 |
0 |
10 |
1 |
2 |
Toxicité muqueuse |
|
|
|
|
|
|
|
|
|
|
|
|
|
Aphtes |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
3 (37.5%) |
0 (NA%) |
0 (NA%) |
Gencives fragilisée |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (12.5%) |
0 (NA%) |
0 (NA%) |
Gingivite |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Hyposialies nocturnes |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (12.5%) |
0 (NA%) |
0 (NA%) |
Langue rouge |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (100.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Mucite |
2 (50.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Mucites, sécheresse |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Sécheresse |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (12.5%) |
0 (NA%) |
0 (NA%) |
Sècheresse |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (12.5%) |
0 (NA%) |
0 (NA%) |
Sécheresse buccale |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Sècheresse buccale |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (12.5%) |
0 (NA%) |
0 (NA%) |
Sécheresse vaginale |
0 (0.0%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Stomatite |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Unknown |
1 |
4 |
6 |
1 |
2 |
0 |
4 |
1 |
4 |
1 |
18 |
1 |
5 |
Toxicité cardiovasculaire |
|
|
|
|
|
|
|
|
|
|
|
|
|
Augmentation volume jambes et cuisses |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Hypertension |
0 (NA%) |
0 (0.0%) |
1 (100.0%) |
2 (100.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Jambes lourdes |
0 (NA%) |
1 (33.3%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Oedème |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Œdème |
0 (NA%) |
2 (66.7%) |
0 (0.0%) |
0 (0.0%) |
1 (100.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Oedèmes MI et visage, tachycardie |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
Palpitations |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (100.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Thrombose |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
Thrombose veineuse |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (100.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Unknown |
5 |
2 |
5 |
0 |
1 |
0 |
2 |
0 |
3 |
2 |
24 |
1 |
5 |
Toxicité ophtalmique |
|
|
|
|
|
|
|
|
|
|
|
|
|
Carré noir champ de vision |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
Difficulté à l'accomodation |
0 (0.0%) |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Diploplie, vision floue, perte des couleurs |
1 (50.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Halo oculaire |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
Sécheresse oculaire |
1 (50.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Unknown |
3 |
4 |
6 |
2 |
2 |
1 |
4 |
1 |
5 |
1 |
24 |
1 |
5 |
Toxicité pulmonaire |
|
|
|
|
|
|
|
|
|
|
|
|
|
Dyspnée |
0 (NA%) |
2 (66.7%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (20.0%) |
0 (NA%) |
0 (0.0%) |
Laryngite |
0 (NA%) |
1 (33.3%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Mucus |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Mucus jaunes |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (20.0%) |
0 (NA%) |
0 (0.0%) |
Oppression thoracique |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (20.0%) |
0 (NA%) |
0 (0.0%) |
Toux |
0 (NA%) |
0 (0.0%) |
2 (66.7%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (20.0%) |
0 (NA%) |
1 (50.0%) |
Toux, dyspnée |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (20.0%) |
0 (NA%) |
0 (0.0%) |
Toux, mucus épais |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (50.0%) |
Toux, oppression thoracique |
0 (NA%) |
0 (0.0%) |
1 (33.3%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Unknown |
5 |
2 |
3 |
2 |
2 |
0 |
4 |
1 |
4 |
2 |
21 |
1 |
3 |
Toxicité générale |
|
|
|
|
|
|
|
|
|
|
|
|
|
Asthénie |
0 (0.0%) |
1 (100.0%) |
2 (100.0%) |
1 (100.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Asthénie, perte d'appétit |
1 (33.3%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
2 (100.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
Asthénie, perte de poids, agueusie |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (11.1%) |
0 (NA%) |
0 (0.0%) |
Asthénie, perte de poids, dysgueusie |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
Dysgueusie |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Fatigue, perte d'appétit |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (11.1%) |
0 (NA%) |
0 (0.0%) |
Kyste sébacé dorsal, maux de gorge |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (11.1%) |
0 (NA%) |
0 (0.0%) |
Perte d'appétit |
1 (33.3%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
2 (22.2%) |
0 (NA%) |
1 (33.3%) |
Perte de poids |
1 (33.3%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
3 (33.3%) |
0 (NA%) |
0 (0.0%) |
Perte de poids, anosmie, dysgueusie |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (11.1%) |
0 (NA%) |
0 (0.0%) |
Unknown |
2 |
4 |
4 |
1 |
1 |
1 |
1 |
1 |
5 |
0 |
17 |
1 |
2 |
Toxicité hématologique |
|
|
|
|
|
|
|
|
|
|
|
|
|
Anémie |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
Epistaxis |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
2 (50.0%) |
0 (NA%) |
0 (0.0%) |
Hématome |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (25.0%) |
0 (NA%) |
0 (0.0%) |
Thrombopénie |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (25.0%) |
0 (NA%) |
0 (0.0%) |
Unknown |
4 |
5 |
6 |
2 |
2 |
1 |
4 |
1 |
5 |
2 |
22 |
1 |
4 |
Toxicité musqulosqueletique |
|
|
|
|
|
|
|
|
|
|
|
|
|
Crampes |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (14.3%) |
0 (NA%) |
0 (0.0%) |
Cruralgie, épanchement de la cheville |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (14.3%) |
0 (NA%) |
0 (0.0%) |
Douleur |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
Douleur au genou |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (33.3%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Douleur aux mollets |
0 (0.0%) |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Douleur dorsale |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (33.3%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Douleur dos, cervicales |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (14.3%) |
0 (NA%) |
0 (0.0%) |
Douleurs |
0 (0.0%) |
1 (25.0%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
2 (28.6%) |
0 (NA%) |
1 (33.3%) |
Douleurs articulaires |
1 (50.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Faiblesse à la jambe |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (33.3%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Faiblesse musculaire |
0 (0.0%) |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Fatigue musculaire, douleur au pied |
0 (0.0%) |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Fracture du fémur |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (14.3%) |
0 (NA%) |
0 (0.0%) |
Fracture du poignet |
1 (50.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Fracture, douleur |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
Mysthénie |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
tendinite |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (14.3%) |
0 (NA%) |
0 (0.0%) |
Unknown |
3 |
1 |
4 |
2 |
2 |
1 |
4 |
0 |
2 |
2 |
19 |
1 |
2 |
Toxicité rénale |
|
|
|
|
|
|
|
|
|
|
|
|
|
Infections urinaires |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
insuffisance renale aigue fonctionnelle |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
Suspiscion d'infection urinaire |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Urines foncées |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Unknown |
5 |
5 |
6 |
2 |
2 |
1 |
3 |
0 |
5 |
2 |
25 |
1 |
4 |
Toxicité hépatique |
|
|
|
|
|
|
|
|
|
|
|
|
|
Ascite |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
Douleur au foie |
0 (NA%) |
0 (NA%) |
2 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
Unknown |
5 |
5 |
4 |
2 |
2 |
1 |
4 |
1 |
4 |
2 |
26 |
1 |
5 |
Toxicité neuroologique |
|
|
|
|
|
|
|
|
|
|
|
|
|
Céphalée, vertige |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
céphalées |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (0.0%) |
Confusion |
1 (50.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Paresthésie |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
1 (33.3%) |
Syndrome de la queue de cheval, tremblements |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
Tremblement, paresthésie |
1 (50.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Trouble du sommeil |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (0.0%) |
Vertige |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
Vertige, céphalée |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
Unknown |
3 |
5 |
3 |
2 |
2 |
1 |
4 |
1 |
5 |
2 |
23 |
1 |
2 |
Toxicité psychiatrique |
|
|
|
|
|
|
|
|
|
|
|
|
|
Anxiété |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
Dépression |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
Trouble de l'humeur |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
2 (100.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
Trouble du sommeil |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
Unknown |
5 |
5 |
6 |
2 |
1 |
1 |
3 |
1 |
3 |
1 |
26 |
1 |
4 |
Toxicité biologique |
|
|
|
|
|
|
|
|
|
|
|
|
|
Augmentation cholestérol, glycémie 0,6 |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Augmentation CPK |
0 (NA%) |
2 (66.7%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Augmentation des CPK |
0 (NA%) |
0 (0.0%) |
2 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Augmentation PAL et CPK |
0 (NA%) |
1 (33.3%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
hypokaliémie |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
Hypokaliémie |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
Unknown |
5 |
2 |
4 |
2 |
2 |
1 |
3 |
1 |
4 |
2 |
25 |
1 |
5 |
##